Completed NA INTERVENTIONAL 2-arm NCT00599560

Vasopressin and V2 Receptor in Meniere's Disease

Sponsor: Osaka City University

Interventions vasopressin, V2 receptor and cyclic AMP

Updated 6 times since 2017 Last updated: Mar 28, 2016 Started: Apr 30, 1998 Primary completion: Sep 30, 2005 Completion: Sep 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Meniere Disease, this trial is completed. The trial is conducted by Osaka City University and has accumulated 6 data snapshots since 1998. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Osaka City University
Osaka University

Data source: Osaka University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Suita, Japan